Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations
研究成果: 雜誌貢獻 › 文章 › 同行評審
16
引文
斯高帕斯(Scopus)